BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Larrubia JR, Benito-Martínez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 2008; 14(47): 7149-7159 [PMID: 19084927 DOI: 10.3748/wjg.14.7149]
URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7149.htm
(0) (0) (14834) (102)
Number Citing Articles
1
Hiroyuki Oshiumi, Kenji Funami, Hussein H. Aly, Misako Matsumoto, Tsukasa Seya. Multi-Step Regulation of Interferon Induction by Hepatitis C Virus. Archivum Immunologiae et Therapiae Experimentalis 2013; 61(2) doi: 10.1007/s00005-012-0214-x
2
Ruben Zamora, Yoram Vodovotz, Qi Mi, Derek Barclay, Jinling Yin, Simon Horslen, David Rudnick, Kathleen M Loomes, Robert H Squires. Data-Driven Modeling for Precision Medicine in Pediatric Acute Liver Failure. Molecular Medicine 2016; 22(1) doi: 10.2119/molmed.2016.00183
3
Haoyang Tian, Simin Zhao, Fujiao Nie, Qiuyue Yin, Suli Wang, Jiayi Liu, Jinhong Ju, Pishan Yang, Chengzhe Yang. The pro-cancer and immunosuppressive activity of macrophage-transformed cancer-associated fibroblasts in oral squamous cell carcinoma. Journal of Advanced Research 2026; 82 doi: 10.1016/j.jare.2025.07.027
4
Issam Tout, Pietro Lampertico, Thomas Berg, Tarik Asselah. Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B. Antiviral Research 2021; 185 doi: 10.1016/j.antiviral.2020.104992
5
Chia-Chen Lin, Shih-Huan Su, Wen-Juei Jeng, Chien-Hao Huang, Wei Teng, Wei-Ting Chen, Yi-Cheng Chen, Chun-Yen Lin, I-Shyan Sheen. CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0724-4
6
Stephen Fahey, Eugene Dempsey, Aideen Long. The role of chemokines in acute and chronic hepatitis C infection. Cellular & Molecular Immunology 2014; 11(1) doi: 10.1038/cmi.2013.37
7
Veronica D. Gonzalez, Alan L. Landay, Johan K. Sandberg. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. Clinical Immunology 2010; 135(1) doi: 10.1016/j.clim.2009.12.005
8
Min Zhang, Yongfang Jiang, Xinqiang Xiao, Milin Peng, Feng Peng, Guozhong Gong. Differences in IP-10, TLR4 and IRF5/3 between SVR and non-SVR HCV-1 patients treated with PEG-IFN and ribavirin. Molecular Medicine Reports 2017; 15(4) doi: 10.3892/mmr.2017.6229
9
Elisabetta Pandolfi, Nadia Panera, Anna Alisi, Emanuela Carloni, Luisa Russo, Ilaria Campagna, Caterina Rizzo, Carlo Concato, Giulia Linardos, Livia Piccioni, Sally Jackson, Alberto Villani, Fabio Midulla, Alberto E. Tozzi. Cytokine expression patterns in hospitalized children with Bordetella pertussis, Rhinovirus or co-infection. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89538-0
10
Noha Mousaad Elemam, Bariaa A. Khalil, Azzam A. Maghazachi. Encyclopedia of Infection and Immunity. 2022;  doi: 10.1016/B978-0-12-818731-9.00061-6
11
Natalia Fonseca Rosário, Geórgia do Nascimento Saraiva, Thalia Medeiros, Mariana Gandini, Gilmar Lacerda, Paulo Emílio Corrêa Leite, Thaís Guaraná Andrade, Elzinandes Leal Azeredo, Analúcia Rampazzo Xavier, Andrea Alice Silva. Successful DAA therapy for chronic hepatitis C reduces HLA-DR on monocytes and circulating immune mediators: A long-term follow-up study. Immunology Letters 2020; 228 doi: 10.1016/j.imlet.2020.09.002
12
Takayuki Abe, Takasuke Fukuhara, Xiauyu Wen, Akinori Ninomiya, Kohji Moriishi, Yoshihiko Maehara, Osamu Takeuchi, Taro Kawai, Shizuo Akira, Yoshiharu Matsuura. CD44 Participates in IP-10 Induction in Cells in Which Hepatitis C Virus RNA Is Replicating, through an Interaction with Toll-Like Receptor 2 and Hyaluronan. Journal of Virology 2012; 86(11) doi: 10.1128/JVI.06872-11
13
Xiao-Wei Xu, Xiao-Xin Wu, Ke-Da Chen, Da-Zhi Chen, Hui-Lin Ou, Jun-Wei Su, Hai-Ying Yu, Hang-Ping Yao, Lan-Juan Li. Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China. Medicine 2018; 97(38) doi: 10.1097/MD.0000000000012403
14
Artem Rubinstein, Igor Kudryavtsev, Natalia Arsentieva, Zoia R. Korobova, Dmitry Isakov, Areg A. Totolian. CXCR3-Expressing T Cells in Infections and Autoimmunity. Frontiers in Bioscience-Landmark 2024; 29(8) doi: 10.31083/j.fbl2908301
15
Marilyn Huckans, Bret E. Fuller, Hannah Olavarria, Anna W. Sasaki, Michael Chang, Kenneth D. Flora, Michael Kolessar, Daniel Kriz, Jeanne R. Anderson, Arthur A. Vandenbark, Jennifer M. Loftis. Multi‐analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection. Brain and Behavior 2014; 4(2) doi: 10.1002/brb3.200
16
Fernanda Cristina Winckler, Aline Marcia Marques Braz, Vanessa Nogueira da Silva, Marjorie de Assis Golim, Vanessa Gutierrez de Andrade, Paulo Eduardo de Abreu Machado, Liciana Vaz de Arruda Silveira, Giovanni Faria Silva. Influence of the inflammatory response on treatment of hepatitis C with triple therapy. Revista da Sociedade Brasileira de Medicina Tropical 2018; 51(6) doi: 10.1590/0037-8682-0137-2018
17
Katrien Van Raemdonck, Philippe E. Van den Steen, Sandra Liekens, Jo Van Damme, Sofie Struyf. CXCR3 ligands in disease and therapy. Cytokine & Growth Factor Reviews 2015; 26(3) doi: 10.1016/j.cytogfr.2014.11.009
18
James M. Crawford, Alastair D. Burt. MacSween's Pathology of the Liver. 2012;  doi: 10.1016/B978-0-7020-3398-8.00001-5
19
Mustapha Si-Tahar, Fany Blanc, Laetitia Furio, Damien Chopy, Viviane Balloy, Monique Lafon, Michel Chignard, Laurence Fiette, Francina Langa, Pierre Charneau, Julien Pothlichet. Protective Role of LGP2 in Influenza Virus Pathogenesis. The Journal of Infectious Diseases 2014; 210(2) doi: 10.1093/infdis/jiu076
20
Yuhua Lin, Yiwen Chai, Jugan Han, Weiheng Shi, Along Gao, Jianmin Ye, Liting Wu. Functional characterization of the CCL25/CCR9 axis in B cell differentiation and antibacterial defense in Nile tilapia. Aquaculture 2026; 619 doi: 10.1016/j.aquaculture.2026.743890
21
M Sadeghi, I Lahdou, H Oweira, V Daniel, P Terness, J Schmidt, K-H Weiss, T Longerich, P Schemmer, G Opelz, A Mehrabi. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. British Journal of Cancer 2015; 113(5) doi: 10.1038/bjc.2015.227
22
Hu Li, Meng-Hao Huang, Jian-Dong Jiang, Zong-Gen Peng. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World Journal of Gastroenterology 2018; 24(47): 5297-5311 doi: 10.3748/wjg.v24.i47.5297
23
Julia Peña-Asensio, Eduardo Sanz-de-Villalobos, Joaquín Miquel, Juan Ramón Larrubia. Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history. World Journal of Hepatology 2020; 12(10): 754-765 doi: 10.4254/wjh.v12.i10.754
24
Qing Lin, Dan Fang, Xinwei Hou, Yingying Le, Jiazhu Fang, Feng Wen, Wanghua Gong, Keqiang Chen, Ji Ming Wang, Shao Bo Su. HCV Peptide (C5A), an Amphipathic α-Helical Peptide of Hepatitis Virus C, Is an Activator of N-Formyl Peptide Receptor in Human Phagocytes. The Journal of Immunology 2011; 186(4) doi: 10.4049/jimmunol.1002340
25
A. Katsounas, M. Trippler, B. Wang, M. Polis, R. A. Lempicki, S. Kottilil, G. Gerken, J. F. Schlaak. CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon‐α therapy and toll‐like receptor 3 signalling. Journal of Viral Hepatitis 2012; 19(2) doi: 10.1111/j.1365-2893.2011.01503.x
26
Noha Elemam, Iman Talaat, Azzam Maghazachi. CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections. Viruses 2022; 14(11) doi: 10.3390/v14112445
27
Hamad I. Al-Ashgar, Mohammed Q. Khan, Ahmed Helmy, Sahar Al-Thawadi, Mohammed N. Al-Ahdal, Nisreen Khalaf, Ahmed Al-Qahtani, Faisal M Sanai. Relationship of interferon-γ-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4. European Journal of Gastroenterology & Hepatology 2013; 25(4) doi: 10.1097/MEG.0b013e32835bc2cf
28
Suvercha Bhardwaj, Fareed Ahmad, Heiner Wedemeyer, Marcus Cornberg, Julian Schulze zur Wiesch, Jan van Lunzen, Shiv K. Sarin, Reinhold E. Schmidt, Dirk Meyer-Olson. Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype. Virology Journal 2016; 13(1) doi: 10.1186/s12985-016-0507-5
29
Jieru Wang, Mrinalini P. Nikrad, Tzulip Phang, Bifeng Gao, Taylor Alford, Yoko Ito, Karen Edeen, Emily A. Travanty, Beata Kosmider, Kevan Hartshorn, Robert J. Mason. Innate Immune Response to Influenza A Virus in Differentiated Human Alveolar Type II Cells. American Journal of Respiratory Cell and Molecular Biology 2011; 45(3) doi: 10.1165/rcmb.2010-0108OC
30
Noha G. Bader El Din, Mohamed A. Anany, Reham M. Dawood, Marwa K. Ibrahim, Reem El-Shenawy, Yasmin S. El Abd, Mostafa K. El Awady. Impact ofOAS1Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients. Viral Immunology 2015; 28(9) doi: 10.1089/vim.2015.0041
31
Yoram Vodovotz, Derek Barclay, Jinling Yin, Robert H. Squires, Ruben Zamora. Dynamics of Systemic Inflammation as a Function of Developmental Stage in Pediatric Acute Liver Failure. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.610861
32
Susanne Johansson, Willem Talloen, Marianne Tuefferd, Jama Darling, Gregory Fanning, Michael W. Fried, Jeroen Aerssens. High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV‐infected patients regardless of DPP4 activity. Liver International 2016; 36(3) doi: 10.1111/liv.12932
33
A. de Niet, J. de Bruijne, M.J. Tempelmans Plat-Sinnige, R.B. Takkenberg, R.A.W. van Lier, H.W. Reesink, E.M.M. van Leeuwen. Upregulation of CXCR3 expression on CD8+ T cells due to the pervasive influence of chronic hepatitis B and C virus infection. Human Immunology 2013; 74(8) doi: 10.1016/j.humimm.2013.04.017
34
Caralee J. Schaefer, Karl Kossen, Sharlene R. Lim, Jiing-Huey Lin, Lin Pan, Williamson Bradford, Patrick F. Smith, Scott D. Seiwert. Danoprevir Monotherapy Decreases Inflammatory Markers in Patients with Chronic Hepatitis C Virus Infection. Antimicrobial Agents and Chemotherapy 2011; 55(7) doi: 10.1128/AAC.00131-11
35
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar, Limin Chen. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated‐Interferon‐α Based Therapy. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/287640
36
Erwin Daniel Brenndörfer, Anette Brass, Juliane Karthe, Gustaf Ahlén, Johannes Georg Bode, Matti Sällberg. Cleavage of the T Cell Protein Tyrosine Phosphatase by the Hepatitis C Virus Nonstructural 3/4A Protease Induces a Th1 to Th2 Shift Reversible by Ribavirin Therapy. The Journal of Immunology 2014; 192(4) doi: 10.4049/jimmunol.1301077
37
Shikha Shrivastava, Eric G. Meissner, Emily Funk, Seerat Poonia, Virender Shokeen, Arun Thakur, Bhawna Poonia, Shiv Kumar Sarin, Nirupma Trehanpati, Shyamasundaran Kottilil. Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis. Hepatology International 2016; 10(6) doi: 10.1007/s12072-016-9733-6
38
F. Cai, Y. Zhao, Q. Chen, Y. Hu, Shibing Su, Yiyu Lu. Serum Cytokine Analysis Reveals Predictors of Progression from Chronic Hepatitis B to Liver Cirrhosis. Folia Biologica 2021; 67(1) doi: 10.14712/fb2021067010028
39
Ilona Argirion, Ruth M. Pfeiffer, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien-Jen Chen, Mei-Hsuan Lee, Allan Hildesheim, Hwai-I Yang, Jill Koshiol. Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00455-8
40
Jae Yoon Jeong, Dae Won Jun, Sol Ji Park, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Soung Won Jeong, Moon Young Kim, Won Kim, Jae-Jun Shim, Hyoung Su Kim, Ki Tae Suk, Sang Bong Ahn. Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study. The Korean Journal of Internal Medicine 2020; 35(5) doi: 10.3904/kjim.2018.273
41
Arnaud Chalin, Benjamin Lefevre, Christelle Devisme, Charlotte Pronier, Virginie Carrière, Vincent Thibault, Laurence Amiot, Michel Samson. Serum CXCL10, CXCL11, CXCL12, and CXCL14 chemokine patterns in patients with acute liver injury. Cytokine 2018; 111 doi: 10.1016/j.cyto.2018.05.029
42
A. S. Moura, R. A. Carmo, A. L. Teixeira, V. H. R. Leite, M. O. C. Rocha. Soluble inflammatory markers as predictors of liver histological changes in patients with chronic hepatitis C virus infection. European Journal of Clinical Microbiology & Infectious Diseases 2010; 29(9) doi: 10.1007/s10096-010-0981-4
43
Lauren E. Kushner, Aaron M. Wendelboe, Laura C. Lazzeroni, Aarthi Chary, Mark A. Winters, Anu Osinusi, Shyam Kottilil, Michael A. Polis, Mark Holodniy, Ravi Jhaveri. Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients. PLoS ONE 2013; 8(4) doi: 10.1371/journal.pone.0060387
44
Tingting Zhang, Long Zhang, Tao Zhang, Jinhai Fan, Kaijie Wu, Zhenfeng Guan, Xinyang Wang, Lei Li, Jer-Tsong Hsieh, Dalin He, Peng Guo. Metformin Sensitizes Prostate Cancer Cells to Radiation Through EGFR/p-DNA-PKCS In Vitro and In Vivo. Radiation Research 2014; 181(6) doi: 10.1667/RR13561.1
45
Marie-Luise Berres, Sonja Asmacher, Jennifer Lehmann, Christian Jansen, Jan Görtzen, Sabine Klein, Carsten Meyer, Holger M. Strunk, Rolf Fimmers, Frank Tacke, Christian P. Strassburg, Christian Trautwein, Tilman Sauerbruch, Hermann Elard Wasmuth, Jonel Trebicka. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt. Journal of Hepatology 2015; 62(2) doi: 10.1016/j.jhep.2014.09.032
46
Malgorzata Krzystek-Korpacka, Marek Zawadzki, Paulina Lewandowska, Krzysztof Szufnarowski, Iwona Bednarz-Misa, Krzysztof Jacyna, Wojciech Witkiewicz, Andrzej Gamian. Distinct Chemokine Dynamics in Early Postoperative Period after Open and Robotic Colorectal Surgery. Journal of Clinical Medicine 2019; 8(6) doi: 10.3390/jcm8060879
47
Seren Oğultekin Teneke, Mehmet Sami Serin, Zehra Öksüz, Gülhan Orekici Temel, Serkan Yaraş, Enver Üçbilek, Orhan Sezgin. Circulating chemokine levels and receptor polymorphisms have potential as biomarkers for fibrosis stages in patients with chronic hepatitis C infection. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10244-5
48
Sumeet Singh, Manjusha Pal, Samita Verma, Mukesh Samant. Cytokine Response Against Major Human Viral Infections. 2025;  doi: 10.1016/B978-0-443-15283-2.00011-7
49
Stephen Burr, Carole Thomas, Joe Brownlie, Victoria Offord, Tracey J. Coffey, Dirk Werling. Potential evidence for biotype-specific chemokine profile following BVDV infection of bovine macrophages. Veterinary Immunology and Immunopathology 2012; 150(1-2) doi: 10.1016/j.vetimm.2012.08.009
50
Dina Ragab, Melissa Laird, Darragh Duffy, Armanda Casrouge, Rasha Mamdouh, Amal Abass, Dina El. Shenawy, Abdelhadi M. Shebl, Wagdi F. Elkashef, Khaled R. Zalata, Mostafa Kamal, Gamal Esmat, Philippe Bonnard, Arnaud Fontanet, Mona Rafik, Matthew L. Albert. CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients. Cytokine 2013; 63(2) doi: 10.1016/j.cyto.2013.04.016
51
A. Pretorius, F.E. Faber, M. van Kleef. Immune gene expression profiling of PBMC isolated from horses vaccinated with attenuated African horsesickness virus serotype 4. Immunobiology 2016; 221(2) doi: 10.1016/j.imbio.2015.09.002
52
Pam Kimball, Felecia McDougan, Richard Stirling. CXCR3 Expression Elevated on Peripheral CD8+Lymphocytes from HIV/HCV Coinfected Individuals. Viral Immunology 2011; 24(6) doi: 10.1089/vim.2011.0035
53
Peng Peng Ip, Annemarie Boerma, Joke Regts, Tjarko Meijerhof, Jan Wilschut, Hans W Nijman, Toos Daemen. Alphavirus-based Vaccines Encoding Nonstructural Proteins of Hepatitis C Virus Induce Robust and Protective T-cell Responses. Molecular Therapy 2014; 22(4) doi: 10.1038/mt.2013.287
54
Marini Stephanie, Yosephine G. Susufi, Ening Krisnuhoni, Rino A. Gani, Evy Yunihastuti, Silvia Lee, Sara Tanaskovic, Patricia Price. Short Communication: Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy. AIDS Research and Human Retroviruses 2016; 32(12) doi: 10.1089/aid.2016.0042
55
Abdulkerim Yilmaz, Hakan Alagozlu, Ozturk Ozdemir, Sema Arici. Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients. Hepatitis Monthly 2014; 14(6) doi: 10.5812/hepatmon.11283
56
Antonios Katsounas, Joerg F. Schlaak, Richard A. Lempicki. CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus. International Reviews of Immunology 2011; 30(5-6) doi: 10.3109/08830185.2011.593105
57
Muttiah Barathan, Rosmawati Mohamed, Jamuna Vadivelu, Li Y. Chang, Alireza Saeidi, Yean K. Yong, M. Ravishankar Ram, Kaliappan Gopal, Vijayakumar Velu, Marie Larsson, Esaki M. Shankar. Peripheral loss of CD8+CD161++TCRVα7·2+ mucosal‐associated invariant T cells in chronic hepatitis C virus‐infected patients. European Journal of Clinical Investigation 2016; 46(2) doi: 10.1111/eci.12581
58
Yuhua Lin, Yiwen Chai, Along Gao, Jugan Han, Yanxi Guo, Yuqing Lin, Liting Wu, Jianmin Ye. CXCL13/CXCR5 axis mediates IgM+ B cell migration through AKT and STAT3 signaling pathways in Nile tilapia (Oreochromis niloticus). Aquaculture 2024; 591 doi: 10.1016/j.aquaculture.2024.741109
59
Olfat Shaker, Yasser Nassar, Shymaa Ayoub, Maissa Elrazki, Amr Zahra. Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4. Journal of Clinical Laboratory Analysis 2016; 30(6) doi: 10.1002/jcla.21974
60
Nassim Dali‐Youcef, Michel Vix, Federico Costantino, Houssein El‐Saghire, Benoit Lhermitte, Cosimo Callari, Jacopo D’Agostino, Silvana Perretta, Stefan Paveliu, Monica Gualtierotti, Edith Dumeny, Marine A. Oudot, Amélie Jaulin, Doulaye Dembélé, Mirjam B. Zeisel, Catherine Tomasetto, Thomas F. Baumert, Michel Doffoël. Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance. Hepatology Communications 2019; 3(9) doi: 10.1002/hep4.1396
61
Bruce L Gilliam, David J Riedel, Robert R Redfield. Clinical use of CCR5 inhibitors in HIV and beyond. Journal of Translational Medicine 2011; 9(S1) doi: 10.1186/1479-5876-9-S1-S9
62
Shulin Qin, John F Alcorn, Jodi K Craigo, Charis Tjoeng, Patrick M Tarwater, Jay K Kolls, Todd A Reinhart. Epigallocatechin-3-Gallate Reduces Airway Inflammation in Mice through Binding to Proinflammatory Chemokines and Inhibiting Inflammatory Cell Recruitment. The Journal of Immunology 2011; 186(6) doi: 10.4049/jimmunol.1002876
63
S. H. HWANG, J. A. LIM, M. J. KIM, H. C. KIM, H. W. LEE, K. Y. YOO, C. W. YOU, K. S. LEE, H. S. KIM. Profiling of differentially expressed genes in haemophilia A with inhibitor. Haemophilia 2012; 18(3) doi: 10.1111/j.1365-2516.2011.02702.x
64
Sheila M. Keating, Jennifer L. Dodge, Philip J. Norris, John Heitman, Stephen J. Gange, Audrey L. French, Marshall J. Glesby, Brian R. Edlin, Patricia S. Latham, Maria C. Villacres, Ruth M. Greenblatt, Marion G. Peters, Jason Blackard. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury—The Women’s Interagency HIV Study. PLOS ONE 2017; 12(9) doi: 10.1371/journal.pone.0181004
65
James M. Crawford, Paulette Bioulac-Sage, Prodromos Hytiroglou. MacSween's Pathology of the Liver. 2024;  doi: 10.1016/B978-0-7020-8228-3.00001-6
66
N. A. Arsentieva, A. V. Semenov, D. A. Zhebrun, E. V. Vasilyeva, Areg A. Totolian. ROLE OF CXCR3 CHEMOKINE RECEPTOR AND ITS LIGANDS IN CERTAIN DISEASES. Medical Immunology (Russia) 2019; 21(4) doi: 10.15789/1563-0625-2019-4-617-632
67
Marie-Luise Berres, Christian Trautwein, Maximilian Schmeding, Dennis Eurich, Frank Tacke, Marcus Bahra, Peter Neuhaus, Ulf P. Neumann, Hermann E. Wasmuth. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. Hepatology 2011; 53(2) doi: 10.1002/hep.24098
68
Moataza H Omran, Mahmoud Khamis, Nada Nasr, Ahmed A Massoud, Samar S Youssef, Noha G. Bader El Din, Reham M Dawood, Khaled Atef, Rehab I Moustafa, Wael Nabil, Ashraf A Tabll, Mostafa K. El Awady. A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients. Hepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.13721
69
Dilihuma Dilimulati, Nuerbiye Nueraihemaiti, Sendaer Hailati, Mengyuan Han, Kayisaier Abudurousuli, Nulibiya Maihemuti, Alhar Baishan, Alfira Aikebaier, Maidina Abulizi, Wenting Zhou. Elucidating the multi-target pharmacological mechanism of Xiaoyandina for the treatment of hepatitis C virus based on bioinformatics and cyberpharmacology studies. Medicine 2025; 104(11) doi: 10.1097/MD.0000000000041793
70
Devi Satarkar, Chinmoy Patra. Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.882017
71
Cristina Stasi, Stefano Milani, Andrea Galli. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes. 2021;  doi: 10.1016/B978-0-12-821927-0.00005-X
72
G. L.‐H. Wong, Y.‐K. Tse, H. L.‐Y. Chan, T. C.‐F. Yip, K. K.‐F. Tsoi, V. W.‐S. Wong. Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B‐related hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2016; 43(7) doi: 10.1111/apt.13548
73
Nabil Azhar, Cordelia Ziraldo, Derek Barclay, David A. Rudnick, Robert H. Squires, Yoram Vodovotz, Ioannis P. Androulakis. Analysis of Serum Inflammatory Mediators Identifies Unique Dynamic Networks Associated with Death and Spontaneous Survival in Pediatric Acute Liver Failure. PLoS ONE 2013; 8(11) doi: 10.1371/journal.pone.0078202
74
Karin Kan, Danny Ka‐Ho Wong, Rex Wan‐Hin Hui, Wai Kay Seto, Man‐Fung Yuen, Lung‐Yi Mak. Plasma interferon‐gamma‐inducible‐protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients. Journal of Gastroenterology and Hepatology 2024; 39(1) doi: 10.1111/jgh.16371
75
Hossein Khorramdelazad, Elham Hakimizadeh, Gholamhossein Hassanshahi, Mohammadtaghi Rezayati, Hossein Sendi, Mohammad Kazemi Arababadi. CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection. Journal of Medical Virology 2013; 85(6) doi: 10.1002/jmv.23510
76
Erwin Daniel Brenndörfer, Anette Brass, Jonas Söderholm, Lars Frelin, Soo Aleman, Johannes Georg Bode, Matti Sällberg. Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production. Gut 2012; 61(4) doi: 10.1136/gut.2010.232116
77
Paul J Rider, Fenyong Liu. Crosstalk between HIV and hepatitis C virus during co-infection. BMC Medicine 2012; 10(1) doi: 10.1186/1741-7015-10-32
78
Julia Peña-Asensio, Henar Calvo, Miguel Torralba, Joaquín Miquel, Eduardo Sanz-de-Villalobos, Juan-Ramón Larrubia. Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C. Cells 2021; 10(3) doi: 10.3390/cells10030538
79
Beicheng Sun, Michael Karin. Inflammation and liver tumorigenesis. Frontiers of Medicine 2013; 7(2) doi: 10.1007/s11684-013-0256-4
80
Shibin Zhang, Yan Zhao, Huiping Yan, Hao Wu, Lai Wei, Yonghong Zhang, Xinyue Chen. Pretreatment serum macrophage inflammatory protein (MIP)-1 levels predict sustained virological responses to re-treatment in patients with chronic hepatitis C virus infection. International Journal of Infectious Diseases 2015; 33 doi: 10.1016/j.ijid.2014.08.021
81
Wen Zhang, Yunyun Fei, Jinming Gao, Bin Liu, Fengchun Zhang. The Role of CXCR3 in the Induction of Primary Biliary Cirrhosis. Clinical and Developmental Immunology 2011; 2011 doi: 10.1155/2011/564062
82
Lanlan Xiao, Xiaoxin Wu, Fen Zhang, Jie Wang, Xiaowei Xu, Lanjuan Li. Changes of inflammatory cytokines/chemokines during ravidasvir plus ritonavir‐boosted danoprevir and ribavirin therapy for patients with genotype 1b hepatitis C infection. Journal of Medical Virology 2020; 92(12) doi: 10.1002/jmv.26161
83
Nora A. Fierro, Flor P. Castro-Garcia, Arturo Panduro. Rethinking cytokine function during hepatitis A and hepatitis C infections. Advances in Bioscience and Biotechnology 2013; 4(07) doi: 10.4236/abb.2013.47A1003
84
Man Yang, Ling Zhou, Hai-Qing Wang, Xiao-Chun Luo, Xue-Ming Dan, Yan-Wei Li. Molecular cloning and expression analysis of CCL25 and its receptor CCR9s from Epinephelus coioides post Cryptocaryon irritans infection. Fish & Shellfish Immunology 2017; 67 doi: 10.1016/j.fsi.2017.06.039
85
Jieru Wang, Mrinalini P. Nikrad, Emily A. Travanty, Bin Zhou, Tzulip Phang, Bifeng Gao, Taylor Alford, Yoko Ito, Piruz Nahreini, Kevan Hartshorn, David Wentworth, Charles A. Dinarello, Robert J. Mason, Samithamby Jeyaseelan. Innate Immune Response of Human Alveolar Macrophages during Influenza A Infection. PLoS ONE 2012; 7(3) doi: 10.1371/journal.pone.0029879
86
G. L.‐H. Wong, H. L.‐Y. Chan, H.‐Y. Chan, C.‐H. Tse, A. M.‐L. Chim, A. O.‐S. Lo, V. W.‐S. Wong. Serum interferon‐inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2016; 43(1) doi: 10.1111/apt.13447
87
Adeeb H. Rahman, Andrea D. Branch. Vitamin D for your patients with chronic hepatitis C?. Journal of Hepatology 2013; 58(1) doi: 10.1016/j.jhep.2012.07.026
88
Poupak Fallahi, Clodoveo Ferri, Silvia Martina Ferrari, Alda Corrado, Domenico Sansonno, Alessandro Antonelli. Cytokines and HCV-Related Disorders. Clinical and Developmental Immunology 2012; 2012 doi: 10.1155/2012/468107
89
Noe Rico Montanari, Chimaobi M. Anugwom, Andre Boonstra, Jose D. Debes. The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma. Cancers 2021; 13(19) doi: 10.3390/cancers13194876
90
Cheng Peng, Bi-Sheng Liu, Robert J. de Knegt, Harry L.A. Janssen, André Boonstra. The response to TLR ligation of human CD16+CD14− monocytes is weakly modulated as a consequence of persistent infection with the hepatitis C virus. Molecular Immunology 2011; 48(12-13) doi: 10.1016/j.molimm.2011.04.008
91
Silvia Martina Ferrari, Poupak Fallahi, Ilaria Ruffilli, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Valeria Mazzi, Michele Colaci, Dilia Giuggioli, Clodoveo Ferri, Alessandro Antonelli. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?. Journal of Immunology Research 2019; 2019 doi: 10.1155/2019/5878960
92
Marie‐Luise Berres, Jennifer Lehmann, Christian Jansen, Jan Görtzen, Carsten Meyer, Daniel Thomas, Henning W. Zimmermann, Daniela Kroy, Fabienne Schumacher, Christian P. Strassburg, Tilman Sauerbruch, Christian Trautwein, Hermann E. Wasmuth, Jonel Trebicka. Chemokine (C‐X‐C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Liver International 2016; 36(3) doi: 10.1111/liv.12922
93
Elia Moreno-Cubero, Robert T Sánchez del Arco, Julia Peña-Asensio, Eduardo Sanz de Villalobos, Joaquín Míquel, Juan Ramón Larrubia. Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?. World Journal of Gastroenterology 2018; 24(17): 1825-1838 doi: 10.3748/wjg.v24.i17.1825
94
Karim Si-Tayeb, Jean-Charles Duclos-Vallée, Marie-Anne Petit. Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal. Journal of Hepatology 2012; 57(3) doi: 10.1016/j.jhep.2012.04.012
95
Edward Hudgens, Dannielle Tompkins, Patricia Boyd, Joan K. Lunney, David Horohov, Cynthia L. Baldwin. Expressed gene sequence of the IFNγ-response chemokine CXCL9 of cattle, horses, and swine. Veterinary Immunology and Immunopathology 2011; 141(3-4) doi: 10.1016/j.vetimm.2011.02.015
96
Fenghuang Pan, Xinbiao Ma, Xiaoqian Tang, Jing Xing, Xiuzhen Sheng, Heng Chi, Wenbin Zhan. Genome characterization of Hirame novirhabdovirus (HIRRV) isolate CNPo2015 and transcriptome analysis of Hirame natural embryo (HINAE) cells infected with CNPo2015. Fish & Shellfish Immunology 2023; 132 doi: 10.1016/j.fsi.2022.108493
97
H.‐B. Kim, S.‐K. Myung, Y.‐J. Lee, B.‐J. Park. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta‐analysis of randomised controlled trials. Journal of Human Nutrition and Dietetics 2018; 31(2) doi: 10.1111/jhn.12503
98
James M. Crawford, Paulette Bioulac-Sage, Prodromos Hytiroglou. Macsween's Pathology of the Liver. 2018;  doi: 10.1016/B978-0-7020-6697-9.00001-7
99
Ivan Kurelac, Snjezana Zidovec Lepej, Ivana Grgic, Lana Gorenec, Neven Papic, Davorka Dusek, Bruno Barsic, Adriana Vince. Chemokine CXCL10 at Week 4 of Treatment Predicts Sustained Virological Response in Patients with Chronic Hepatitis C. Journal of Interferon & Cytokine Research 2012; 32(8) doi: 10.1089/jir.2012.0006
100
Sergey M. Ivanov, Olga A. Tarasova, Vladimir V. Poroikov. Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1199482
101
Takashi Iwata, Takuma Fujii, Kenji Morii, Miyuki Saito, Juri Sugiyama, Hiroshi Nishio, Tohru Morisada, Kyoko Tanaka, Tomonori Yaguchi, Yutaka Kawakami, Daisuke Aoki. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia. International Journal of Clinical Oncology 2015; 20(1) doi: 10.1007/s10147-014-0680-8
102
Víctor G Martínez, Noelia M Canseco, Laura Hidalgo, Jaris Valencia, Ana Entrena, Lidia M Fernández‐Sevilla, Carmen Hernández‐López, Rosa Sacedón, Angeles Vicente, Alberto Varas. A discrete population of IFN λ‐expressing BDCA3hi dendritic cells is present in human thymus. Immunology & Cell Biology 2015; 93(7) doi: 10.1038/icb.2015.22
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.